Trials / Completed
CompletedNCT01873222
OPtical Frequency Domain Imaging Versus INtravascular Ultrasound in Percutaneous Coronary InterventiON - OPINION Imaging
OPtical Frequency Domain Imaging vs. INtravascular Ultrasound in Percutaneous Coronary InterventiON - OPINION Imaging
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 106 (actual)
- Sponsor
- Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan · Academic / Other
- Sex
- All
- Age
- 20 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
This study is the sub-study of OPINION Trial. (UMIN000010580) The aim of this study is to evaluate how Optical frequency domain imaging (OFDI) or Intravascular Ultrasound (IVUS) imaging technology influence to the Percutaneous Coronary Intervention (PCI) strategy.
Detailed description
Optical frequency domain imaging (OFDI) is a novel, high resolution intravascular imaging modality. Intravascular ultrasound (IVUS) is a widely used conventional imaging modality for achieving optimal stent deployment. This study is the sub-study of OPINION Trial. (UMIN000010580) The aim of this study is to evaluate how OFDI or IVUS imaging technology influence to the Percutaneous Coronary Intervention (PCI) strategy. We will enroll the first 100 patients who have enrolled in the main-study of OPINION trial.(UMIN000010580). We will assess lesions by the other device in addition to the assigned device in the main study at the time of post-PCI. We will then assess lesions by OFDI at a 8-month follo-up.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | OFDI-guided PCI & IVUS | * Assessment by IVUS at post-PCI * Assessment by OFDI at a 8-month follow-up |
| DEVICE | IVUS-guided PCI & OFDI | * Assessment by OFDI at post-PCI * Assessment by OFDI at a 8-month follow-up |
Timeline
- Start date
- 2013-06-01
- Primary completion
- 2016-07-01
- Completion
- 2016-07-01
- First posted
- 2013-06-10
- Last updated
- 2016-07-14
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01873222. Inclusion in this directory is not an endorsement.